Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment.

Sun, Chun-Yong; Yang, Le-Le; Zhao, Pan; Yan, Pei-Zheng; Li, Jia; Zhao, Dong-Sheng

Sun, Chun-Yong; Yang, Le-Le; Zhao, Pan; Yan, Pei-Zheng; Li, Jia; Zhao, Dong-Sheng.

Afiliação

Sun CY; College of Pharmacy, Shandong University of Traditional Chinese Medicine, No. 4655 Daxue Road, Jinan, 250355, China.
Yang LL; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, 999078, China.
Zhao P; College of Pharmacy, Shandong University of Traditional Chinese Medicine, No. 4655 Daxue Road, Jinan, 250355, China.
Yan PZ; College of Pharmacy, Shandong University of Traditional Chinese Medicine, No. 4655 Daxue Road, Jinan, 250355, China.
Li J; College of Pharmacy, Shandong University of Traditional Chinese Medicine, No. 4655 Daxue Road, Jinan, 250355, China.
Zhao DS; College of Pharmacy, Shandong University of Traditional Chinese Medicine, No. 4655 Daxue Road, Jinan, 250355, China. dongshengpw2008@163.com.

Hereditas ; 159(1): 44, 2022 Dec 01.

Article em En | MEDLINE | ID: mdl-36451177

Assuntos

Hepatopatia Gordurosa não Alcoólica; Humanos; Hepatopatia Gordurosa não Alcoólica/tratamento farmacológico; Hepatopatia Gordurosa não Alcoólica/genética; Simulação de Acoplamento Molecular; Farmacologia em Rede; Fosfatidilinositol 3-Quinases; Lipídeos

Palavras-chave

Cynarine; Integration analysis; Molecular docking; Network pharmacology; Non-alcoholic fatty liver disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google